Enterprise Value
333.8M
Cash
213.3M
Avg Qtr Burn
-23.03M
Short % of Float
16.63%
Insider Ownership
1.39%
Institutional Own.
98.58%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Losmapimod Details Muscle weakness, Muscle degeneration | Phase 3 Data readout | |
Pociredir (FTX-6058) Details Sickle cell disease | Phase 1b Initiation | |
Losmapimod Details COVID-19 | Failed Discontinued |